Charles River
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Charles River and other ETFs, options, and stocks.About CRL
Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions.
CEOJames C. Foster
CEOJames C. Foster
Employees20,100
Employees20,100
HeadquartersWilmington, Massachusetts
HeadquartersWilmington, Massachusetts
Founded1947
Founded1947
Employees20,100
Employees20,100
CRL Key Statistics
Market cap8.40B
Market cap8.40B
Price-Earnings ratio-128.81
Price-Earnings ratio-128.81
Dividend yield—
Dividend yield—
Average volume1.02M
Average volume1.02M
High today—
High today—
Low today—
Low today—
Open price$169.26
Open price$169.26
Volume0.00
Volume0.00
52 Week high$230.02
52 Week high$230.02
52 Week low$91.86
52 Week low$91.86
CRL News
Simply Wall St 41m
A Look at Charles River Laboratories' Valuation Following Strategic ReproTracker Partnership with ToxysCharles River Laboratories International (CRL) has entered a strategic collaboration with Toxys, expanding its developmental and reproductive toxicology service...
Simply Wall St 1d
Could Charles River Redefine Its Competitive Edge with New Non-Animal Toxicology Platform?Charles River Laboratories International and Toxys recently announced a collaboration granting Charles River’s clients access to ReproTracker®, an in vitro stem...
TipRanks 6d
Charles River, Toxys announce ReproTracker collaborationCharles River (CRL) and Toxys announced a collaboration that offers Charles River’s clients access to ReproTracker, a human stem cell-based in vitro assay that...
Analyst ratings
50%
of 20 ratingsBuy
45%
Hold
50%
Sell
5%
People also own
Based on the portfolios of people who own CRL. This list is generated using Robinhood data, and it’s not a recommendation.